Fundraising Fox
/Companies
Sign in

Lifeward

NASDAQ: LFWD

Marlborough, US · Incorporated in Israel · 1 known investors

Find your way into Lifeward

Sign up to see every warm intro you have to Lifeward

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Lifeward team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Lifeward develops products for physical rehabilitation and recovery, aimed at improving function and daily-life health for people with conditions such as spinal cord injury, brain injury, stroke, and multiple sclerosis. Its offerings serve rehabilitation and orthopedic/sports medicine care settings.

BiotechHealthtechMedical DevicesRobotics

Founders & leadership

CR
Charles RemsbergExecutive
LJLarry Jasinski
Larry JasinskiExecutive
ML
Michael LawlessExecutive
AAAlmog Adar
Almog AdarExecutive
JLJeannine Lynch
Jeannine LynchExecutiveJeannine Lynch is an executive officer at Lifeward with experience in strategic operations, market access, and product launch across healthcare settings, including specialty and rare disease markets.
HL
Hadar LevyExecutive
WM
William Mark GrantExecutive
OG
Ori GonExecutive
OK
Ofir KorenExecutive
MGMark Grant
Mark GrantPresident, Chief Executive Officer and Director

Board

JDJeff Dykan
Jeff DykanBoard directorPartner at SCP Vitalife Partners
WBWayne B. Weisman
Wayne B. WeismanBoard directorPartner at SCP Vitalife Partners

Investors · 1

Reported raises · per SEC filings

Form D private placements

$114.2M disclosed across 9 of 11 rounds · 2019–2026

▶$11.2MraisedJul 2026 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • William Mark GrantExecutive Officer, Director
Amount sold
$11.2M
First sale
Jul 2026
Incorporated
Other, Israel
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$20MraisedApr 2026 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • William Mark GrantExecutive Officer, Director
Amount sold
$20M
First sale
Mar 2026
Incorporated
Other, Israel
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedJan 2025 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Randel RichnerDirector
  • Joseph TurkDirector
  • Charles RemsbergExecutive Officer
  • Larry JasinskiExecutive Officer, Director
  • Michael LawlessExecutive Officer
  • Almog AdarExecutive Officer
  • Jeannine LynchExecutive Officer
  • Michael SwinfordDirector
  • John William PoduskaDirector
  • Hadar LevyDirector
  • Robert J MarshallDirector
Offering amount
$5M
Amount sold
$5M
Sales commissions
$350K
Placement agents
H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC
First sale
Jan 2025
Incorporated
Other, Israel
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$16.3MraisedOct 2021 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Wayne B. WeismanDirector
  • John William PoduskaDirector
  • Arik DanDirector
  • Larry JasinskiExecutive Officer, Director
  • Yasushi IchikiDirector
  • Randel RichnerDirector
  • Ori GonExecutive Officer
  • Yohanan EngelhardtDirector
  • Jeff DykanDirector
Offering amount
$16.3M
Amount sold
$16.3M
Sales commissions
$2.8M
Placement agents
H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC
First sale
Sep 2021
Incorporated
Other, Israel
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$40MraisedFeb 2021 · 22 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Randel RichnerDirector
  • Arik DanDirector
  • Yasushi IchikiDirector
  • John William PoduskaDirector
  • Yohanan EngelhardtDirector
  • Jeff DykanDirector
  • Ori GonExecutive Officer
  • Larry JasinskiExecutive Officer, Director
  • Wayne B. WeismanDirector
Offering amount
$40M
Amount sold
$40M
Sales commissions
$3.4M
Placement agents
H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC
First sale
Feb 2021
Incorporated
Other, Israel
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8MraisedDec 2020 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Yohanan EngelhardtDirector
  • Arik DanDirector
  • Randel RichnerDirector
  • Yasushi IchikiDirector
  • Jeff DykanDirector
  • John William PoduskaDirector
  • Larry JasinskiExecutive Officer, Director
  • Ori GonExecutive Officer
  • Ofir KorenExecutive Officer
  • Wayne B. WeismanDirector
Offering amount
$8M
Amount sold
$8M
Sales commissions
$680K
Placement agents
H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC
First sale
Dec 2020
Incorporated
Other, Israel
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.5MraisedJul 2020 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • John William PoduskaDirector
  • Yasushi IchikiDirector
  • Ofir KorenExecutive Officer
  • Yohanan EngelhardtDirector
  • Jeff DykanDirector
  • Larry JasinskiExecutive Officer, Director
  • Arik DanDirector
  • Wayne B. WeismanDirector
  • Ori GonExecutive Officer
Offering amount
$8.8M
Amount sold
$4.5M
Sales commissions
$765K
Placement agents
H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC
First sale
Jul 2020
Incorporated
Other, Israel
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10.8MofferedJun 2019 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Larry JasinskiExecutive Officer, Director
  • Ori GonExecutive Officer
  • Ofir KorenExecutive Officer
  • Jeff DykanDirector
  • Wayne B. WeismanDirector
  • John William PoduskaDirector
  • Yohanan EngelhardtDirector
  • Peter WehrlyDirector
  • Yasushi IchikiDirector
  • Arik DanDirector
  • Chunlin (Allen) HanDirector
Offering amount
$10.8M
Sales commissions
$922.2K
Placement agents
H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC
First sale
Jun 2019
Incorporated
Other, Israel
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Lifeward do?
Lifeward develops products for physical rehabilitation and recovery, aimed at improving function and daily-life health for people with conditions such as spinal cord injury, brain injury, stroke, and multiple sclerosis. Its offerings serve rehabilitation and orthopedic/sports medicine care settings.
Who are Lifeward's investors?
Lifeward's investors include SCP Vitalife Partners.
How much funding has Lifeward raised?
Lifeward has disclosed $114.2M raised across 9 of its 11 known rounds.
Where is Lifeward headquartered?
Lifeward is headquartered in Marlborough, US.